The Aims Platform integrates cutting-edge AI and secure automation to simplify
participant-based research, accelerate breakthroughs, and extend your global reach.
Unlock insights with compliance-first AI, driving rigorous, inclusive, scalable, and cost-effective research in a HIPAA/GDPR-compliant ecosystem.
Intuitive workflows and intelligent automation designed to streamline, accelerate, and secure your participant-based research.
Initiate your research faster.
Leverage intuitive tools for ethics documentation, informed consent, and comprehensive surveys and interviews—condensing preparation from months to days.
Multilingual AI participant interactions.
RAchel, our multilingual AI assistant recruits, enrolls, and engages participants worldwide. She manages thousands of conversations, boosting enrollment and retention.
Easily capture detailed, accurate data.
RAchel efficiently executes complex web, phone, or SMS surveys, records and transcribes interactions, analyzes call sentiment, and generates codebooks and metadata tables.
Accelerate discovery with actionable data.
Instantly generate thematic and predictive analysis along with automated visual reports, transforming complex research data into clear insights—without tedious manual processing.
Promptly resolve complex participant needs.
RAchel delegates sensitive or complex cases to your human research team, ensuring timely follow-ups, enhanced participant care, and continuous study integrity.
Your entire study, visualized instantly.
Track real-time enrollment updates and create detailed study flowcharts. Monitor participant progress and access interaction logs in one centralized platform.
Fluent, Precise, and Always-On—RAchel seamlessly manages participant interactions from first contact to actionable insights, so you can focus on discovery, not logistics.
Listen to me engage study participants!
Listen to RAchel Connect
Listen to RAchel Schedule
Listen to RAchel Survey
Our research assistants reflect global diversity—offering a wide range of languages, dialects, accents, and culturally-competent interactions.
Reduce your study timelines from months to minutes, while enhancing participant engagement and ensuring high-quality, culturally-responsive data collection.
RAchel seamlessly guides each phase of your research—from initial preparation through final insights—with AI-powered precision, secure data handling, and automated efficiency.
Key Benefits
Prepare
Key Benefits
Recruit & Enroll
Key Benefits
Capture Data 24/7
Key Benefits
Monitor Progress
Key Benefits
Analyze & Report
Existing security solutions inadequately protect short-lived data, causing institutions to restrict AI use and limit research innovation. Aims’ patent-pending EVX fully secures transient data—including sensitive participant-AI interactions—to ensure compliance, privacy, and safe AI adoption without compromising institutional policies or ethics.
Unlock innovation in any field—tailored, scalable, and compliance-first AI solutions designed to power your sector’s unique needs.
Aims’ highly cost-effective and globally scalable platform accelerates breakthrough discoveries. Our patent-pending EVX platform utilizes bank-grade encryption and zero-trust transient data architecture to keep sensitive patient data secure and fully compliant. Quickly streamline IRB and ethics processes, and rapidly deploy surveys and interviews—reducing timelines from months to days. RAchel, our advanced multilingual AI assistant, automates participant engagement, connecting researchers with diverse and previously inaccessible populations due to cost and language barriers. Powerful automation ensures unmatched data integrity, allowing your teams to focus on deeper collaboration, actionable insights, and accelerated breakthroughs—boosting research productivity worldwide.
Aims delivers inclusive, cost-effective, and globally scalable solutions. Powered by our advanced EVX security platform, Aims guarantees robust compliance and secure data management, empowering researchers to overcome language barriers and infrastructure challenges—even in low-resource settings with high mobile use. RAchel, our multilingual AI assistant, automates participant engagement, effectively reaching diverse communities, ensuring accurate data collection, and driving rapid community involvement. Dramatically reduce costs, expand your research capabilities, and quickly address critical public health challenges—accelerating insights for lasting global impact.
Aims significantly accelerates clinical trials, optimize patient engagement, and speed time-to-market for critical therapies. Our EVX platform guarantees robust regulatory compliance, data security, and privacy, ensuring safe handling of sensitive clinical data. RAchel, our multilingual AI assistant, automates global patient recruitment, real-time monitoring, and data collection, delivering exceptional data quality for both traditional and adaptive trials. Dramatically improve cost efficiency and streamline processes, allowing research teams to strategically focus on innovation—transforming analytics and automation into faster regulatory approvals and a stronger competitive advantage.
Aims transforms customer experience and market research with unmatched agility and global scalability. Built by Ivy League scientists, our platform applies academic-grade rigorto corporate data collection and analysis. Leveraging our patent-pending EVX security platform, your sensitive data remains fully protected, ensuring data privacyand compliance with standards like SOC 2 and GDPR. RAchel, our multilingual AI assistant, automates thousands of simultaneous interactions, rapidly collecting and analyzing valuable feedback. Replace manual processes with intelligent automation and powerful real-time analytics, fueling competitive advantage. Accelerate decisions, swiftly respond to market changes, and confidently expand global customer reach—all within one compliant ecosystem.
Aims helps Web3, blockchain, and crypto projects rapidly achieve sustainable user adoption through structured, data-driven strategies. Leveraging advanced wallet analytics and on-chain insights, Aims ensures unmatched trust, transparency, and protection of sensitive user data via our secure EVX platform. RAchel, our multilingual AI assistant, intelligently matches beta testers based on wallet histories and blockchain engagement patterns, automating precise feedback collection and sentiment analysis to deliver a truly frictionless experience. Gain investor-grade insights from predictive trends, automated analytics, and detailed reporting—empowering strategic decisions that accelerate adoption, deepen community engagement, and optimize decentralized user experiences.
Transform slow, costly research into rapid, scalable discovery. Whether running global clinical trials or student-led pilot studies, AIms empowers your team to focus on innovation—
Explore actual case studies showing how RAchel reduces workload and accelerates timelines
Study Tasks: Designed and conducted 10-min survey (with skip logic) to 15 young adults. Automatically cleaned, managed, and analyzed study data—delivering clear results directly to researchers.
Results
Study Tasks:
Study Tasks:
Study Tasks: Designed and conducted 10-min survey (with skip logic) to 15 young adults. Automatically cleaned, managed, and analyzed study data—delivering clear results directly to researchers.
Results
Study Tasks:
Study Tasks: Designed and conducted 10-min survey (with skip logic) to 15 young adults. Automatically cleaned, managed, and analyzed study data—delivering clear results directly to researchers.
Results
Aims dramatically reduces the complexity, time, and cost of participant-based research. Researchers gain greater capacity, global reach, and scalable, inclusive studies previously out of reach. From student pilot projects to global clinical trials, Aims accelerates insights that matter.
Automate repetitive tasks and
streamline every stage of research.
Instantly engage global participants.
Reduce participant onboarding from
2 weeks to just 10 minutes.
Run more studies. reach diverse populations, use fewer resources.